{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "55294f73",
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests\n",
    "import json\n",
    "import warnings\n",
    "from urllib3.exceptions import InsecureRequestWarning\n",
    "\n",
    "warnings.simplefilter(\"ignore\", InsecureRequestWarning)\n",
    "\n",
    "HEADERS = {\n",
    "    \"accept\": \"application/json\",\n",
    "    \"content-type\": \"application/json\",\n",
    "    \"authorization\": \"Token b85ee49cde4db576eee2522c6c340e7f967537e2\"\n",
    "    }\n",
    "\n",
    "def query_clinical_result(\n",
    "    indication_name=None,\n",
    "    drug_modality=None,\n",
    "    locations=None,\n",
    "    target=None,\n",
    "    lead_company=None,\n",
    "    phase=None,\n",
    "    route_of_administration=None,\n",
    "    drug_feature=None,\n",
    "    drug_name=None,\n",
    "    nctids=None,\n",
    "    limit=30,\n",
    "    page=1\n",
    "):\n",
    "    \"\"\"\n",
    "    Calls the clinical result API with the provided filters.\n",
    "\n",
    "    Args:\n",
    "        indication_name (list): List of indication names\n",
    "        drug_modality (list or dict): Drug modality list or dict with data list and logic (or/and)\n",
    "        locations (list or dict): Locations list or dict with data list and logic (or/and)\n",
    "        target (list or dict): Targets list or dict with data list and logic (or/and)\n",
    "        lead_company (list): List of lead companies\n",
    "        phase (list): List of clinical phases\n",
    "        route_of_administration (list or dict): ROA list or dict with data list and logic (or/and)\n",
    "        drug_feature (list or dict): Drug features list or dict with data list and logic (or/and)\n",
    "        drug_name (list or dict): Drug names list or dict with data list and logic (or/and)\n",
    "        nctids (list): List of NCT IDs\n",
    "        limit (int): Number of results to return (max 30)\n",
    "        page (int): Page number for pagination\n",
    "\n",
    "    Returns:\n",
    "        dict: API response data\n",
    "    \"\"\"\n",
    "    \n",
    "    clinical_trial_api_url = f\"https://staging.noahai.co/api/workflow/clinical-result/\"\n",
    "    \n",
    "    # Helper function to convert list to dict with \"or\" logic if needed\n",
    "    def ensure_dict_format(param):\n",
    "        if isinstance(param, list):\n",
    "            return {\"data\": param, \"logic\": \"or\"}\n",
    "        return param\n",
    "    \n",
    "    # Build filter object with provided parameters\n",
    "    filter_dict = {}\n",
    "    if indication_name: filter_dict[\"indication_name\"] = indication_name\n",
    "    \n",
    "    # Convert parameters to dicts with \"or\" logic if they're lists\n",
    "    if drug_modality: filter_dict[\"drug_modality\"] = ensure_dict_format(drug_modality)\n",
    "    if locations: filter_dict[\"locations\"] = ensure_dict_format(locations)\n",
    "    if target: filter_dict[\"target\"] = ensure_dict_format(target)\n",
    "    if lead_company: filter_dict[\"lead_company\"] = lead_company\n",
    "    if phase: filter_dict[\"phase\"] = phase\n",
    "    if route_of_administration: filter_dict[\"route_of_administration\"] = ensure_dict_format(route_of_administration)\n",
    "    if drug_feature: filter_dict[\"drug_feature\"] = ensure_dict_format(drug_feature)\n",
    "    if drug_name: filter_dict[\"drug_name\"] = ensure_dict_format(drug_name)\n",
    "    if nctids: filter_dict[\"nctids\"] = nctids\n",
    "    \n",
    "    body = {\"filters\": filter_dict, \"limit\": limit, \"page\": page}\n",
    "    \n",
    "    response = requests.post(clinical_trial_api_url, data=json.dumps(body), headers=HEADERS, timeout=240, allow_redirects=True, verify=False)\n",
    "    try: ret = response.json()\n",
    "    except: ret = response.text\n",
    "    return ret\n",
    "\n",
    "def query_drug_compete(\n",
    "    location=None,\n",
    "    drug_modality=None,\n",
    "    indication_name=None,\n",
    "    drug_names=None,\n",
    "    company=None,\n",
    "    target=None,\n",
    "    drug_feature=None,\n",
    "    route_of_administration=None,\n",
    "    phase=None,\n",
    "    limit=30,\n",
    "    page=1\n",
    "):\n",
    "    \"\"\"\n",
    "    Calls the drug compete API with the provided filters.\n",
    "\n",
    "    Args:\n",
    "        location (list or dict): Locations list or dict with data list and logic (or/and)\n",
    "        drug_modality (list or dict): Drug modality list or dict with data list and logic (or/and)\n",
    "        indication_name (list): List of indication names\n",
    "        drug_names (list or dict): Drug names list or dict with data list and logic (or/and)\n",
    "        company (list): List of lead companies\n",
    "        target (list or dict): Targets list or dict with data list and logic (or/and)\n",
    "        drug_feature (list or dict): Drug features list or dict with data list and logic (or/and)\n",
    "        route_of_administration (list or dict): ROA list or dict with data list and logic (or/and)\n",
    "        phase (list): List of clinical phases\n",
    "        limit (int): Number of results to return (max 30)\n",
    "        page (int): Page number for pagination\n",
    "\n",
    "    Returns:\n",
    "        dict: API response data\n",
    "    \"\"\"\n",
    "    \n",
    "    drug_compete_api_url = f\"https://staging.noahai.co/api/workflow/drug-compete/\"\n",
    "    \n",
    "    # Helper function to convert list to dict with \"or\" logic if needed\n",
    "    def ensure_dict_format(param):\n",
    "        if isinstance(param, list):\n",
    "            return {\"data\": param, \"logic\": \"or\"}\n",
    "        return param\n",
    "    \n",
    "    # Build filter object with provided parameters\n",
    "    filter_dict = {}\n",
    "    if location: filter_dict[\"location\"] = location\n",
    "    if drug_modality: filter_dict[\"drug_modality\"] = ensure_dict_format(drug_modality)\n",
    "    if indication_name: filter_dict[\"indication_name\"] = indication_name\n",
    "    if drug_names: filter_dict[\"drug_names\"] = ensure_dict_format(drug_names)\n",
    "    if company: filter_dict[\"company\"] = company\n",
    "    if target: filter_dict[\"target\"] = ensure_dict_format(target)\n",
    "    if drug_feature: filter_dict[\"drug_feature\"] = ensure_dict_format(drug_feature)\n",
    "    if route_of_administration: filter_dict[\"route_of_administration\"] = ensure_dict_format(route_of_administration)\n",
    "    if phase: filter_dict[\"phase\"] = phase\n",
    "    \n",
    "    body = {\"filters\": filter_dict, \"limit\": limit, \"page\": page}\n",
    "    \n",
    "    response = requests.post(drug_compete_api_url, data=json.dumps(body), headers=HEADERS, timeout=240, allow_redirects=True, verify=False)\n",
    "    try: ret = response.json()\n",
    "    except: ret = response.text\n",
    "    return ret"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "c210c2fa",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'results': [{'id': 59350, 'nct_id': 'NCT04505722', 'primary_id': 'NCT04505722', 'last_updated': '20\n",
      "{'results': [{'name': 'REC-648647', 'other_names': [], 'lead_company': ['Recursion Pharmaceuticals']\n",
      "30\n",
      "30\n",
      "{'id': 59350, 'nct_id': 'NCT04505722', 'primary_id': 'NCT04505722', 'last_updated': '2022-02-01', 'official_title': 'A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older', 'lead_company': 'Johnson & Johnson (JNJ)', 'partner_companies': None, 'drug_name': ['Jcovden/Ad26.COV2.S'], 'drug_modality': ['Vaccine'], 'drug_feature': ['Precision Medicine'], 'route_of_administration': ['Intramuscular (IM) Injection'], 'indication_name': ['Coronavirus disease 19 infection'], 'target': ['Immune System', 'SARS-CoV-2'], 'phase': 'III', 'phase_mapping': ['III'], 'current_status': 'Final Data', 'gender': 'Both', 'actual_enrollment': 44325, 'locations': ['Argentina', 'Brazil', 'Chile', 'Colombia', 'Mexico', 'Peru', 'South Africa', 'United States'], 'design': '- Single-dose Ad26.COV2.S COVID-19 vaccine trial (5×10¹⁰ viral particles) vs placebo [[1]](https://www.jnj.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints-in-interim-analysis-of-its-phase-3-ensemble-trial)[[2]](https://www.janssen.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints)[[3]](https://www.janssen.com/japan/press-release/20210201)\\n- Phase III ENSEMBLE study: randomized, double-blind, placebo-controlled [[4]](https://www.nejm.org/doi/full/10.1056/NEJMoa2101544)\\n- Total enrollment: 43,783 participants across 8 countries [[4]](https://www.nejm.org/doi/full/10.1056/NEJMoa2101544)\\n- Geographic distribution: US (44%), Central/South America (41%), South Africa (15%) [[1]](https://www.jnj.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints-in-interim-analysis-of-its-phase-3-ensemble-trial)[[2]](https://www.janssen.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints)[[3]](https://www.janssen.com/japan/press-release/20210201)\\n- Demographics: 45% female, 55% male; 34% age >60; 41% with comorbidities [[1]](https://www.jnj.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints-in-interim-analysis-of-its-phase-3-ensemble-trial)[[2]](https://www.janssen.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints)[[3]](https://www.janssen.com/japan/press-release/20210201)\\n- Median follow-up: 4 months; 8,940 participants with ≥6 months follow-up [[5]](https://www.nejm.org/doi/full/10.1056/NEJMoa2117608)', 'efficacy': '- Primary endpoint (14-day): 56.3% efficacy (95% CI: 51.3-60.8) against moderate to severe-critical COVID-19 [[5]](https://www.nejm.org/doi/full/10.1056/NEJMoa2117608)\\n- Primary endpoint (28-day): 52.9% efficacy (95% CI: 47.1-58.1) against moderate to severe-critical COVID-19 [[5]](https://www.nejm.org/doi/full/10.1056/NEJMoa2117608)\\n- Severe-critical COVID-19: 74.6% efficacy (95% CI: 64.7-82.1) [[5]](https://www.nejm.org/doi/full/10.1056/NEJMoa2117608)\\n- Medical intervention: 75.6% efficacy (95% CI: 54.3-88.0) [[5]](https://www.nejm.org/doi/full/10.1056/NEJMoa2117608)\\n- COVID-19 related death: 82.8% efficacy (95% CI: 40.5-96.8) [[5]](https://www.nejm.org/doi/full/10.1056/NEJMoa2117608)\\n- Any SARS-CoV-2 infection: 41.7% efficacy (95% CI: 36.3-46.7) [[5]](https://www.nejm.org/doi/full/10.1056/NEJMoa2117608)\\n- US-specific efficacy: 69.7% (95% CI: 60.7-76.9) against reference strain and alpha variant [[5]](https://www.nejm.org/doi/full/10.1056/NEJMoa2117608)\\n- Protection maintained for ≥6 months [[5]](https://www.nejm.org/doi/full/10.1056/NEJMoa2117608)', 'safety': '- Generally mild-to-moderate adverse events profile [[5]](https://www.nejm.org/doi/full/10.1056/NEJMoa2117608)\\n- Overall fever rate: 9%, Grade 3 fever: 0.2% [[1]](https://www.jnj.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints-in-interim-analysis-of-its-phase-3-ensemble-trial)[[2]](https://www.janssen.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints)[[3]](https://www.janssen.com/japan/press-release/20210201)\\n- No anaphylaxis cases reported [[1]](https://www.jnj.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints-in-interim-analysis-of-its-phase-3-ensemble-trial)[[2]](https://www.janssen.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints)[[3]](https://www.janssen.com/japan/press-release/20210201)\\n- Mortality: 3 deaths in vaccine group (non-COVID-19 related), 16 in placebo group (5 COVID-19 related) [[4]](https://www.nejm.org/doi/full/10.1056/NEJMoa2101544)\\n- No new safety concerns identified in final analysis [[5]](https://www.nejm.org/doi/full/10.1056/NEJMoa2117608)\\n- Balanced serious adverse events between vaccine and placebo groups [[4]](https://www.nejm.org/doi/full/10.1056/NEJMoa2101544)', 'key_findings': [{'finding': 'Single-dose vaccine demonstrated 52.9% overall efficacy against moderate to severe-critical COVID-19 at 28 days post-vaccination, with higher protection (74.6%) against severe-critical disease', 'timestamp': '2022-02-09'}, {'finding': 'Efficacy against COVID-19-related death was 82.8% (95% CI: 40.5-96.8), with protection lasting 6 months or longer', 'timestamp': '2022-02-09'}, {'finding': 'Geographic variation in efficacy: 69.7% in US, lower in regions with prevalent variants (P.1, C.37, and B.1.621)', 'timestamp': '2022-02-09'}, {'finding': 'Demonstrated neutralizing activity against Delta variant at higher levels than Beta variant', 'timestamp': '2021-07-01'}, {'finding': 'Safety profile showed mainly mild-to-moderate adverse events with no significant safety concerns across all analyzed timepoints', 'timestamp': '2022-02-09'}], 'sources': [{'id': 1, 'link': 'https://www.jnj.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints-in-interim-analysis-of-its-phase-3-ensemble-trial', 'title': 'Press Release 01/29/2021', 'published': '2021-01-29'}, {'id': 2, 'link': 'https://www.janssen.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints', 'title': 'Press Release 01/29/2021', 'published': '2021-01-29'}, {'id': 3, 'link': 'https://www.janssen.com/japan/press-release/20210201', 'title': 'Press Release 02/01/2021', 'published': '2021-01-29'}, {'id': 4, 'link': 'https://www.nejm.org/doi/full/10.1056/NEJMoa2101544', 'title': 'New England Journal of Medicine 04/21/2021', 'published': '2021-04-21'}, {'id': 5, 'link': 'https://www.nejm.org/doi/full/10.1056/NEJMoa2117608', 'title': 'New England Journal of Medicine 02/09/2022', 'published': '2022-02-09'}], 'label': 'positive'}\n",
      "{'name': 'selectin inhibitors, Organon', 'other_names': ['selectin inhibitors'], 'lead_company': ['Merck & Co.', 'Ontogen'], 'partner_companies': [], 'target': [], 'drug_modality': ['Small Molecule'], 'drug_feature': [], 'route_of_administration': ['Unknown'], 'indication': 'Dermatitis atopic', 'phase': 'Preclinical', 'location': 'USA', 'id': '00010d4b-0bec-4dfe-ac9b-81e600d32977_181_USA'}\n"
     ]
    }
   ],
   "source": [
    "full_trial_params_example = {\n",
    "    \"indication_name\": [\n",
    "        \"Degeneration\"\n",
    "    ],\n",
    "    \"drug_modality\": {\n",
    "        \"data\": [\n",
    "            \"Small Molecule Drugs\"\n",
    "        ],\n",
    "        \"logic\": \"or\"\n",
    "    },\n",
    "    \"locations\": {\n",
    "        \"data\": [\n",
    "            \"United States\"\n",
    "        ],\n",
    "        \"logic\": \"or\"\n",
    "    },\n",
    "    \"target\": {\n",
    "        \"data\": [\n",
    "            \"ATP7B gene\"\n",
    "        ],\n",
    "        \"logic\": \"or\"\n",
    "    },\n",
    "    \"lead_company\": [\n",
    "        \"Pfizer Inc. (PFE)\"\n",
    "    ],\n",
    "    \"phase\": [\n",
    "        \"I\"\n",
    "    ],\n",
    "    \"route_of_administration\": {\n",
    "        \"data\": [\n",
    "            \"Intraarterial\"\n",
    "        ],\n",
    "        \"logic\": \"or\"\n",
    "    },\n",
    "    \"drug_feature\": {\n",
    "        \"data\": [\n",
    "            \"505b2\"\n",
    "        ],\n",
    "        \"logic\": \"or\"\n",
    "    },\n",
    "    \"drug_name\": {\n",
    "        \"data\": [\n",
    "            \"Brimochol F\"\n",
    "        ],\n",
    "        \"logic\": \"or\"\n",
    "    },\n",
    "    \"nctids\": [\n",
    "        \"NCT0123\"\n",
    "    ]\n",
    "}\n",
    "\n",
    "full_drug_params_example = {\n",
    "    \"location\": [\n",
    "        \"USA\"\n",
    "    ],\n",
    "    \"drug_modality\": {\n",
    "        \"data\": [\n",
    "            \"Protein Degrader\"\n",
    "        ],\n",
    "        \"logic\": \"or\"\n",
    "    },\n",
    "    \"indication_name\": [\n",
    "        \"Porphyria acute\"\n",
    "    ],\n",
    "    \"drug_names\": {\n",
    "        \"data\": [\n",
    "            \"Aiphagan P\"\n",
    "        ],\n",
    "        \"logic\": \"or\"\n",
    "    },\n",
    "    \"company\": [\n",
    "        \"Aravax Pvt Ltd\"\n",
    "    ],\n",
    "    \"target\": {\n",
    "        \"data\": [\n",
    "            \"FXYD domain containing ion transport regulator 5(RIC, HSPC113, KCT1, PRO6241, FXYD5, OIT2, DYSAD, IWU1)\"\n",
    "        ],\n",
    "        \"logic\": \"or\"\n",
    "    },\n",
    "    \"drug_feature\": {\n",
    "        \"data\": [\n",
    "            \"Bacterial Product\"\n",
    "        ],\n",
    "        \"logic\": \"or\"\n",
    "    },\n",
    "    \"route_of_administration\": {\n",
    "        \"data\": [\n",
    "            \"Intralymphatic\"\n",
    "        ],\n",
    "        \"logic\": \"or\"\n",
    "    },\n",
    "    \"phase\": [\n",
    "        \"III\"\n",
    "    ]\n",
    "}\n",
    "\n",
    "trial_params_example = {\n",
    "    \"locations\": {\n",
    "        \"data\": [\n",
    "            \"United States\"\n",
    "        ],\n",
    "        \"logic\": \"or\"\n",
    "    }\n",
    "}\n",
    "\n",
    "drug_params_example = {\n",
    "    \"location\": [\n",
    "        \"USA\"\n",
    "    ]\n",
    "}\n",
    "\n",
    "trials_result = query_clinical_result(**trial_params_example)\n",
    "drugs_result = query_drug_compete(**drug_params_example)\n",
    "\n",
    "print(str(trials_result)[:100])\n",
    "print(str(drugs_result)[:100])\n",
    "\n",
    "print(len(trials_result['results']))\n",
    "print(len(drugs_result['results']))\n",
    "\n",
    "print(trials_result['results'][0] if trials_result['results'] else \"No results found\")\n",
    "print(drugs_result['results'][1] if drugs_result['results'] else \"No results found\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "3a6b4146",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== 每个模板生成 1 条预览 ===\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "模板进度:   0%|          | 0/10 [00:00<?, ?it/s]"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "模板进度:  10%|█         | 1/10 [00:01<00:13,  1.54s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "★ C1\n",
      "Netherlands 市场上的 Obesity 药物竞争格局如何？\n",
      "参数: indication='Obesity', location='Netherlands'\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "模板进度:  20%|██        | 2/10 [00:03<00:11,  1.50s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "★ C2\n",
      "在 Netherlands，ADC 类药物目前的竞争格局是什么？\n",
      "参数: modality='ADCs', location='Netherlands'\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "模板进度:  30%|███       | 3/10 [00:47<02:28, 21.27s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "× C3 - 连降级后仍未找到数据（staging 数据过少？）\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "模板进度:  40%|████      | 4/10 [01:33<03:05, 30.85s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "× C4 - 连降级后仍未找到数据（staging 数据过少？）\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "模板进度:  50%|█████     | 5/10 [02:01<02:28, 29.76s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "★ C5\n",
      "Germany 已获批的系统性红斑狼疮（SLE）药物有哪些？\n",
      "参数: indication='SLE', phase='Approved', location='Germany'\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "模板进度:  60%|██████    | 6/10 [02:01<01:19, 19.90s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "★ I1\n",
      "Semaglutide 与 Tirzepatide 的 III 期研究相比，哪款减肥效果更好？\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "模板进度:  70%|███████   | 7/10 [02:45<01:22, 27.61s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "× I2 - 连降级后仍未找到数据（staging 数据过少？）\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "模板进度:  80%|████████  | 8/10 [03:29<01:05, 32.79s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "× I3 - 连降级后仍未找到数据（staging 数据过少？）\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "模板进度:  90%|█████████ | 9/10 [04:14<00:36, 36.68s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "× I4 - 连降级后仍未找到数据（staging 数据过少？）\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "模板进度: 100%|██████████| 10/10 [04:57<00:00, 29.72s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "× I5 - 连降级后仍未找到数据（staging 数据过少？）\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "\"\"\"\n",
    "preview_10_templates.py  (v3, 2025-05-19)\n",
    "────────────────────────────────────────────────────────────\n",
    "• 10 个模板各打印 1 条真实问句\n",
    "• 自适应降级：先(适应症+国家)→(适应症)→(国家)→(无过滤)\n",
    "• 修复 clinical-result 只能用 'locations' 字段的 TypeError\n",
    "\"\"\"\n",
    "\n",
    "import random, time, sys\n",
    "from collections import defaultdict\n",
    "from typing import Dict, Any\n",
    "from tqdm import tqdm\n",
    "\n",
    "# ───────────────────────────────────────────────────────────\n",
    "# 0. 你的 API 包装（请按实际文件名替换）\n",
    "# ───────────────────────────────────────────────────────────\n",
    "\n",
    "# ───────────────────────────────────────────────────────────\n",
    "# 1. 扩大热点池：20 × 20\n",
    "# ───────────────────────────────────────────────────────────\n",
    "HOT_INDICATIONS = [\n",
    "    # 代谢 / 自身免疫\n",
    "    \"Obesity\", \"Type 2 Diabetes\", \"NASH\", \"Hypercholesterolemia\",\n",
    "    \"Psoriasis\", \"Systemic lupus erythematosus\", \"Rheumatoid arthritis\",\n",
    "    \"Crohn disease\", \"Ulcerative colitis\", \"Atopic dermatitis\",\n",
    "    # 肿瘤高频\n",
    "    \"Non-small cell lung cancer stage IV\", \"Small cell lung cancer\",\n",
    "    \"HER2-positive breast cancer\", \"Triple-negative breast cancer\",\n",
    "    \"Colorectal cancer\", \"Ovarian cancer\", \"Prostate cancer\",\n",
    "    \"Pancreatic cancer\", \"Melanoma\", \"Multiple myeloma\"\n",
    "]\n",
    "\n",
    "HOT_LOCATIONS = [\n",
    "    \"USA\", \"China\", \"Japan\", \"Germany\", \"France\",\n",
    "    \"United Kingdom\", \"Canada\", \"Australia\", \"Brazil\", \"India\",\n",
    "    \"Spain\", \"Italy\", \"South Korea\", \"Netherlands\", \"Sweden\",\n",
    "    \"Russia\", \"Mexico\", \"South Africa\", \"Saudi Arabia\", \"Singapore\"\n",
    "]\n",
    "\n",
    "# ───────────────────────────────────────────────────────────\n",
    "# 2. 10 个模板\n",
    "# ───────────────────────────────────────────────────────────\n",
    "TEMPLATES: Dict[str, Dict[str, Any]] = {\n",
    "    # 药物竞争格局类\n",
    "    \"C1\": {\n",
    "        \"api\": \"drug\",\n",
    "        \"base\": {},  # 仅靠模糊过滤\n",
    "        \"text\": lambda c: f\"{c['location']} 市场上的 {c['indication']} 药物竞争格局如何？\\n\"\n",
    "                         f\"参数: indication='{c['indication']}', location='{c['location']}'\"\n",
    "    },\n",
    "    \"C2\": {\n",
    "        \"api\": \"drug\",\n",
    "        \"base\": {\n",
    "            \"drug_modality\": {\"data\": [\"Antibody-Drug Conjugates, ADCs\"], \"logic\": \"or\"}\n",
    "        },\n",
    "        \"text\": lambda c: f\"在 {c['location']}，ADC 类药物目前的竞争格局是什么？\\n\"\n",
    "                         f\"参数: modality='ADCs', location='{c['location']}'\"\n",
    "    },\n",
    "    \"C3\": {\n",
    "        \"api\": \"drug\",\n",
    "        \"base\": {\n",
    "            \"target\": {\"data\": [\"EGFR\"], \"logic\": \"or\"}\n",
    "        },\n",
    "        \"text\": lambda c: f\"如果要开发新的 EGFR 靶向药，目前 {c['location']} 针对 {c['indication']} 的竞争环境如何？\\n\"\n",
    "                         f\"参数: indication='{c['indication']}', target='EGFR', location='{c['location']}'\"\n",
    "    },\n",
    "    \"C4\": {\n",
    "        \"api\": \"drug\",\n",
    "        \"base\": {\n",
    "            \"target\": {\"data\": [\"GLP-1\"], \"logic\": \"or\"},\n",
    "            \"route_of_administration\": {\"data\": [\"Oral (PO)\"], \"logic\": \"or\"}\n",
    "        },\n",
    "        \"text\": lambda c: f\"{c['location']} 口服 GLP-1 药物分别用于哪些适应症、临床阶段分布如何？\\n\"\n",
    "                         f\"参数: target='GLP-1', ROA='Oral', location='{c['location']}'\"\n",
    "    },\n",
    "    \"C5\": {\n",
    "        \"api\": \"drug\",\n",
    "        \"base\": {\n",
    "            \"indication_name\": [\"Systemic lupus erythematosus\"],\n",
    "            \"phase\": [\"Approved\"]\n",
    "        },\n",
    "        \"text\": lambda c: f\"{c['location']} 已获批的系统性红斑狼疮（SLE）药物有哪些？\\n\"\n",
    "                         f\"参数: indication='SLE', phase='Approved', location='{c['location']}'\"\n",
    "    },\n",
    "    # 临床结果洞察类\n",
    "    \"I1\": {\n",
    "        \"api\": \"trial\",\n",
    "        \"base\": {\n",
    "            \"indication_name\": [\"Obesity\"],\n",
    "            \"drug_name\": {\"data\": [\"Semaglutide\", \"Tirzepatide\"], \"logic\": \"or\"},\n",
    "            \"phase\": [\"III\"]\n",
    "        },\n",
    "        \"text\": lambda c: f\"Semaglutide 与 Tirzepatide 的 III 期研究相比，哪款减肥效果更好？\"\n",
    "    },\n",
    "    \"I2\": {\n",
    "        \"api\": \"trial\",\n",
    "        \"base\": {\n",
    "            \"drug_modality\": {\"data\": [\"Antibody-Drug Conjugates, ADCs\"], \"logic\": \"or\"},\n",
    "            \"indication_name\": [\"breast tumor\"]\n",
    "        },\n",
    "        \"text\": lambda c: \"乳腺癌领域目前表现最优的 ADC 药物是哪一款？\"\n",
    "    },\n",
    "    \"I3\": {\n",
    "        \"api\": \"trial\",\n",
    "        \"base\": {\n",
    "            \"target\": {\"data\": [\"EGFR\"], \"logic\": \"or\"},\n",
    "            \"phase\": [\"III\"],\n",
    "            \"indication_name\": [\"Non-small cell lung cancer stage IV\"]\n",
    "        },\n",
    "        \"text\": lambda c: \"在晚期 NSCLC III 期试验中，哪款 EGFR 靶向药表现最佳？\"\n",
    "    },\n",
    "    \"I4\": {\n",
    "        \"api\": \"trial\",\n",
    "        \"base\": {\n",
    "            \"drug_name\": {\"data\": [\"Kadcyla\", \"Enhertu\"], \"logic\": \"or\"},\n",
    "            \"phase\": [\"III\"]\n",
    "        },\n",
    "        \"text\": lambda c: \"请撰写推广报告，突出 Kadcyla 相比 Enhertu 的 III 期优势。\"\n",
    "    },\n",
    "    \"I5\": {\n",
    "        \"api\": \"trial\",\n",
    "        \"base\": {\n",
    "            \"drug_modality\": {\"data\": [\"siRNA/RNAi\"], \"logic\": \"or\"}\n",
    "        },\n",
    "        \"text\": lambda c: \"小核酸（siRNA/RNAi）药物在哪些适应症被证实有效？请列出关键证据。\"\n",
    "    }\n",
    "}\n",
    "\n",
    "# ───────────────────────────────────────────────────────────\n",
    "# 3. 通用：把 Noah 返回记录抽取成 ctx\n",
    "# ───────────────────────────────────────────────────────────\n",
    "def extract_ctx(item: Dict) -> Dict[str, str]:\n",
    "    ctx = defaultdict(str)\n",
    "    # location (两种可能)\n",
    "    loc = item.get(\"location\") or item.get(\"locations\") or \"\"\n",
    "    if isinstance(loc, list):\n",
    "        loc = loc[0]\n",
    "    elif isinstance(loc, dict):\n",
    "        loc = loc.get(\"data\", [\"\"])[0]\n",
    "    ctx[\"location\"] = loc\n",
    "\n",
    "    # indication\n",
    "    ind = item.get(\"indication_name\") or item.get(\"indication\") or \"\"\n",
    "    if isinstance(ind, list):\n",
    "        ind = ind[0]\n",
    "    ctx[\"indication\"] = ind\n",
    "    return ctx\n",
    "\n",
    "# ───────────────────────────────────────────────────────────\n",
    "# 4. 根据 API 类型拼 fuzzy 过滤\n",
    "#    drug:  location → 'location'\n",
    "#    trial: location → 'locations':{'data': …}\n",
    "# ───────────────────────────────────────────────────────────\n",
    "def merge_filters(api_type: str, base: Dict, ind: str = None, loc: str = None) -> Dict:\n",
    "    filt = base.copy()\n",
    "    if ind:\n",
    "        filt.setdefault(\"indication_name\", [ind])\n",
    "    if loc:\n",
    "        if api_type == \"drug\":\n",
    "            filt.setdefault(\"location\", [loc])\n",
    "        else:  # trial\n",
    "            filt.setdefault(\"locations\", {\"data\": [loc], \"logic\": \"or\"})\n",
    "    return filt\n",
    "\n",
    "# ───────────────────────────────────────────────────────────\n",
    "# 5. 自适应降级查询：逐步放宽直到拿到数据\n",
    "# ───────────────────────────────────────────────────────────\n",
    "def fetch_one(api_type: str, base: Dict, max_try: int = 60):\n",
    "    \"\"\"\n",
    "    返回 (record, ctx)；若找不到 → (None, None)\n",
    "    \"\"\"\n",
    "    # 构造 4 级降级组合\n",
    "    combos = []\n",
    "    for ind in HOT_INDICATIONS:\n",
    "        for loc in HOT_LOCATIONS:\n",
    "            combos.append((ind, loc))\n",
    "    combos += [(ind, None) for ind in HOT_INDICATIONS]\n",
    "    combos += [(None, loc) for loc in HOT_LOCATIONS]\n",
    "    combos.append((None, None))\n",
    "\n",
    "    random.shuffle(combos)  # 随机化，减少热门冲突\n",
    "    tries = 0\n",
    "    for ind, loc in combos:\n",
    "        tries += 1\n",
    "        if tries > max_try:\n",
    "            break\n",
    "\n",
    "        filt = merge_filters(api_type, base, ind, loc)\n",
    "        if api_type == \"drug\":\n",
    "            resp = query_drug_compete(**filt)\n",
    "        else:\n",
    "            resp = query_clinical_result(**filt)\n",
    "\n",
    "        results = resp.get(\"results\", []) if isinstance(resp, dict) else []\n",
    "        if results:\n",
    "            rec = random.choice(results)\n",
    "            return rec, extract_ctx(rec)\n",
    "        time.sleep(0.3)      # 轻限流\n",
    "    return None, None\n",
    "\n",
    "# ───────────────────────────────────────────────────────────\n",
    "# 6. 主流程：每模板 1 条\n",
    "# ───────────────────────────────────────────────────────────\n",
    "def main():\n",
    "    print(\"\\n=== 每个模板生成 1 条预览 ===\")\n",
    "    for key in tqdm(TEMPLATES, desc=\"模板进度\"):\n",
    "        cfg  = TEMPLATES[key]\n",
    "        api  = cfg[\"api\"]\n",
    "        base = cfg[\"base\"]\n",
    "        rec, ctx = fetch_one(api, base)\n",
    "        if rec:\n",
    "            print(f\"\\n★ {key}\\n{cfg['text'](ctx)}\")\n",
    "        else:\n",
    "            print(f\"\\n× {key} - 连降级后仍未找到数据（staging 数据过少？）\")\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    main()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "8b5bda07",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'error': 'the JSON object must be str, bytes or bytearray, not dict'}\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import json\n",
    "\n",
    "def call_slot_fill_tool(prompt, tool, language=\"en\"):\n",
    "    \"\"\"\n",
    "    Question -> query parameters, used to query Noah AI database, text in json out\n",
    "    Expected time to run: < 15s\n",
    "    Output: {'result': 'success', 'data': <dict>}\n",
    "    Available tools include:\n",
    "    [\n",
    "        \"General-Inference\",\n",
    "        \"Medical-Search\",\n",
    "        \"Web-Search\",\n",
    "        \"Clinical-Trial-Result-Analysis\",\n",
    "        \"Drug-Analysis\",\n",
    "        \"Catalyst-Event-Analysis\"\n",
    "    \"\"\"\n",
    "    noah_api_url = f\"https://staging.noahai.co/api/tool_test/\"\n",
    "    body = {\"language\":\"en\", \"user_prompt\":prompt, \"tool\":tool, \"slot_fill\":True}\n",
    "    headers = {\n",
    "        \"accept\": \"application/json\",\n",
    "        \"content-type\": \"application/json\",\n",
    "        \"authorization\": \"Token ab2af44c17490f0c3c3b221b0f6fc2c20d62590a\"}\n",
    "    response = requests.post(noah_api_url, data=json.dumps(body), headers=headers, timeout=30, allow_redirects=True, verify=False)\n",
    "    try: ret = response.json()\n",
    "    except: ret = response.text\n",
    "    return ret\n",
    "\n",
    "def call_tool(prompt, tool, language=\"en\"):\n",
    "    \"\"\"\n",
    "    Question -> report, text in text out\n",
    "    Expected time to run: ~2min\n",
    "    Output: {'result': 'success', 'data': <txt>}\n",
    "    Available tools include:\n",
    "    [\n",
    "        \"General-Inference\",\n",
    "        \"Medical-Search\",\n",
    "        \"Web-Search\",\n",
    "        \"Clinical-Trial-Result-Analysis\",\n",
    "        \"Drug-Analysis\",\n",
    "        \"Catalyst-Event-Analysis\"\n",
    "    \"\"\"\n",
    "    noah_api_url = f\"https://staging.noahai.co/api/tool_test/\"\n",
    "    body = {\"language\": language, \"user_prompt\":prompt, \"tool\":tool, \"slot_fill\":False}\n",
    "    headers = {\n",
    "        \"accept\": \"application/json\",\n",
    "        \"content-type\": \"application/json\",\n",
    "        \"authorization\": \"Token ab2af44c17490f0c3c3b221b0f6fc2c20d62590a\"}\n",
    "    response = requests.post(noah_api_url, data=json.dumps(body), headers=headers, timeout=240, allow_redirects=True, verify=False)\n",
    "    try: ret = response.json()\n",
    "    except: ret = response.text\n",
    "    return ret\n",
    "\n",
    "def call_agent(prompt, language=\"en\"):\n",
    "    \"\"\"\n",
    "    Question -> report, text in text out\n",
    "    Expected time to run: ~10-12min\n",
    "    Output: {'result': 'success', 'data': <txt>}\n",
    "    \"\"\"\n",
    "    noah_api_url = f\"https://staging.noahai.co/api/tool_test/\"\n",
    "    body = {\"language\": language, \"user_prompt\":prompt, \"tool\": \"agent\"}\n",
    "    headers = {\n",
    "        \"accept\": \"application/json\",\n",
    "        \"content-type\": \"application/json\",\n",
    "        \"authorization\": \"Token b85ee49cde4db576eee2522c6c340e7f967537e2\"}\n",
    "    response = requests.post(noah_api_url, data=json.dumps(body), headers=headers, timeout=1200, allow_redirects=True, verify=False)\n",
    "    try: ret = response.json()\n",
    "    except: ret = response.text\n",
    "    return ret\n",
    "\n",
    "#print(call_slot_fill_tool('减肥药的最新竞争格局', 'Drug-Analysis'))\n",
    "# print(call_tool('减肥药的最新竞争格局', 'Drug-Analysis'))\n",
    "print(call_agent('减肥药的最新竞争格局'))\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "gpt",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.19"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
